Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Alirocumab, Praluent(R) in the light of studies2016 | First Faculty of Medicine
- Prevention of atherosclerosis2012 | First Faculty of Medicine
- Dual antiagregant therapy, indication and risk in elderly patient2012 | First Faculty of Medicine
- Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy2012 | First Faculty of Medicine
- Modern risk factors of atherosclerosis2012 | First Faculty of Medicine
- Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?2011 | First Faculty of Medicine
- Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk2011 | First Faculty of Medicine
- Prevalence of risk factors of cardiovascular diseases in men with erectile dysfunction. Are they as frequent as we believe?2011 | First Faculty of Medicine
- Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children2011 | First Faculty of Medicine
Loading network view...